ILMN — ILLUMINA, INC.

—
Nasdaq · Unknown · Unknown · CIK 1110803 ·
Last close
$202.61
Market Cap
$30.59B
52W High
$309.35
52W Low
$112.65
ADV30
2,229,679
Next earnings
2026-10-29

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 — — — — — — —
Mar 2026 1,091,000,000 721,000,000 209,000,000 134,000,000 6,559,000,000 1,089,000,000 3,883,000,000
Dec 2025 1,159,000,000 759,000,000 211,000,000 334,000,000 6,644,000,000 1,418,000,000 3,921,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,128,000,000
Investing CF
$-358,000,000
Financing CF
$-800,000,000
CapEx
$-161,000,000
Dividends Paid
—
Buybacks
$-784,000,000
EPS Diluted TTM
$5.81
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-258,000,000
Inventory
$611,000,000
Receivables
$738,000,000
ST Investments
$66,000,000
EBIT TTM
$1,160,000,000
Pretax Income TTM
$1,060,000,000
Interest Exp TTM
$100,000,000
Analysts
20

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,538,999,808
EBITDA
$1,226,000,000
Free Cash Flow
$997,500,032
Enterprise Value
$36,525,490,176
Total Cash
$1,336,999,936
Total Debt
$2,228,000,000
Shares Out
151,000,000
Trailing EPS
$5.36
Book Value
$18.80
ROE
32.4%
ROA
9.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,343,000,000 817,000,000 850,000,000 6,644,000,000 3,921,000,000 2,723,000,000 1,079,000,000
Dec 2024 4,372,000,000 600,000,000 -1,223,000,000 6,303,000,000 3,930,000,000 2,373,000,000 837,000,000
Dec 2023 4,504,000,000 -222,000,000 -1,161,000,000 10,111,000,000 4,366,000,000 5,745,000,000 478,000,000
Dec 2022 4,584,000,000 354,000,000 -4,404,000,000 12,252,000,000 5,653,000,000 6,599,000,000 392,000,000

TTM Snapshot

Revenues TTM
$4,493,000,000
NetIncome TTM
$825,000,000
OpCashFlow TTM
—
Assets (Latest)
$6,650,000,000
Forward EPS
$6.13

Max Pain — expiry 2026-12-18

max pain strike: $210.00 · spot: $210.01 · call oi: 4,019 · put oi: 2,210
Expected Move to 2026-12-18: ±$28.10 (13.38%) — implied range $181.91 – $238.11 · ATM straddle on $210.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
KBGGY Kongsberg Gruppen ASA/ADR $30.72B $17.46 —
DISPF Disco Corporation/ADR $30.41B $280.38 —
RSHGY RESONA HOLDINGS INC $30.11B $26.96 —
CKHGF Capitec Limited/ADR $31.74B $274.02 —
CQP Cheniere Energy Partners, L.P. $29.35B $60.64 —

News headlines (Yahoo Finance, 1h cache)

Genomic Data Set for RWE Applications - Global Strategic Business Report 2026: Capitalize on 16% CAGR and $1.5B in Total Revenue by 2032 with Illumina, Caris Life Sciences and Datavant
2026-11-18 15:38 · Yahoo
Illumina Stock Outlook: Is Wall Street Bullish or Bearish?
2026-11-18 10:33 · Yahoo
Illumina Sees Strong Clinical Demand, but Research Recovery Remains in Question
2026-11-17 14:13 · Yahoo
Illumina (ILMN) Stock Sees Modest Fair Value Lift As Analysts Debate Growth Outlook
2026-11-13 05:13 · Yahoo
Is Illumina Stock Worth The Wait?
2026-11-11 15:29 · Yahoo
Global Biotechnology Market to Reach $5 Trillion by 2032, Driven by Biopharmaceuticals, Gene Editing and Sustainable Innovation | Features Profiles of Danaher, Roche, Illumina, Merck, Thermo Fisher an
2026-11-11 14:44 · Yahoo
Carrier Screening - Global Strategic Business Report 2026: Secure Your Share of a $7.6 Billion Market by 2032 | Features Competitive Intelligence on Illumina, Natera, BGI Genomics, and Myriad Genetics
2026-11-11 14:25 · Yahoo
Whole Exome Sequencing - Global Strategic Business Report 2026: Capitalize on 19.5% CAGR to $2.3 Billion by 2032 as Illumina, Thermo Fisher Scientific, BGI Genomics, and QIAGEN Accelerate
2026-11-11 14:20 · Yahoo
Single-Cell Analysis - Global Strategic Business Report 2026: Capitalize on 20.4% CAGR as Illumina, Thermo Fisher Scientific, Bio-Rad and Agilent Battle for Shares in the $26.1 Billion Market by 2032
2026-11-11 14:18 · Yahoo
Human Identification - Global Strategic Business Report 2026: Capitalize on 10.1% CAGR to $1.9 Billion by 2032 | Thermo Fisher, Illumina, Qiagen and Bio-Rad Vie for Shares
2026-11-11 14:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.